Amarin Corp Plc (AMRN)

[Whalatane]

Capt https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.050276

The risk reduction ( and therefore potential cost savings ) in this subgroup is dramatic .
The event lines separate very early and separation is very evident at the 3 yr pt.
Yes we would need buy end to some extent from the Health Depts in Germany , France and Italy.

My understanding is that CAD patients are a lot more adherent to taking their meds after being admitted for a CV event .
Recruiting should be a lot easier and quicker then R-IT since theres a lot of followup with these patients in the first months following a PCI

Analysis Event (%) Rate/1000 pt-yr
Event (%) Rate/1000 pt-yr
Coronary Revascularization
1st occurrence event 376 (9.20) 22.50
544 (13.30) 33.67
2nd occurrence event 66 (1.61) 3.77
3rd occurrence event 14 (0.34) 0.80
130 (3.18) 7.57
38 (0.93) 2.19

Kiwi